Opioïdes

Substance

The effect of craving on retention and treatment switching under buprenorphine-naloxone and methadone models of care for non-heroin opioid use disorder: Exploratory analyses from a pragmatic, randomized controlled trial

McAnulty C, Bastien G, Abboud A, Bahremand A, Ledjiar O, Socias ME, Le Foll B, Juteau LC, Jutras-Aswad D; OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse. J Subst Use Addict Treat. 2025 Sep;176:209743. doi: 10.1016/j.josat.2025.209743. Epub 2025 Jun 24. PMID: 40571059. CONSULTER

The effect of craving on retention and treatment switching under buprenorphine-naloxone and methadone models of care for non-heroin opioid use disorder: Exploratory analyses from a pragmatic, randomized controlled trial Lire la suite »

Binge Drug Injection in a Cohort of People Who Inject Drugs in Montreal: Characterizing the Substances and Social Contexts Involved

Minoyan N, Høj SB, Jutras-Aswad D, Larney S, Martel-Laferrière V, Sylvestre MP, Bruneau J. Int J Ment Health Addict. 2025;23(3):1908-1919. doi: 10.1007/s11469-023-01207-7. Epub 2023 Dec 4. PMID: 40703246; PMCID: PMC12279887

Binge Drug Injection in a Cohort of People Who Inject Drugs in Montreal: Characterizing the Substances and Social Contexts Involved Lire la suite »

Opioid consumption frequency and its associations with potential life problems during opioid agonist treatment in individuals with prescription-type opioid use disorder: exploratory results from the OPTIMA Study

Bouthillier A, Bastien G, McAnulty C, Bakouni H, Le Foll B, Socias ME, Jutras-Aswad D. Harm Reduct J. 2025 Feb 8;22(1):14. doi: 10.1186/s12954-025-01157-4. PMID: 39923043; PMCID: PMC11806552.

Opioid consumption frequency and its associations with potential life problems during opioid agonist treatment in individuals with prescription-type opioid use disorder: exploratory results from the OPTIMA Study Lire la suite »

Characteristics of supervised injection site clients and factors associated with requiring overdose intervention, Montreal, Canada, 2018-2022

Zolopa C, Brothers TD, Leclerc P, Mary JF, Morissette C, Bruneau J, Martin NK, Hyshka E, Larney S. Int J Drug Policy. 2025 Mar;137:104711. doi: 10.1016/j.drugpo.2025.104711. Epub 2025 Jan 21. PMID: 39842392

Characteristics of supervised injection site clients and factors associated with requiring overdose intervention, Montreal, Canada, 2018-2022 Lire la suite »